BlackRock Amends Geron Corp. Stake, Maintains Significant Position
Ticker: GERN · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 886744
| Field | Detail |
|---|---|
| Company | Geron Corp (GERN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals
TL;DR
**BlackRock still owns a big chunk of Geron, signaling institutional confidence.**
AI Summary
BlackRock Inc. has updated its ownership stake in Geron Corp. as of December 31, 2023, filing an Amendment No. 14 to its Schedule 13G. This filing indicates that BlackRock, a major institutional investor, continues to hold a significant position in Geron's Common Stock. For investors, this signals continued institutional confidence in Geron, which could be a positive indicator for the stock's stability and future prospects.
Why It Matters
This filing shows that a major institutional investor, BlackRock, still holds a substantial stake in Geron Corp., which can be a vote of confidence for current and potential shareholders.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate negative risks.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, which can be a factor in assessing institutional confidence, but should also conduct their own due diligence on Geron Corp.'s fundamentals.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Geron Corp. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- Amendment No. 14 (number) — the specific amendment number to the Schedule 13G
Forward-Looking Statements
- BlackRock will likely maintain a significant stake in Geron Corp. throughout 2024. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Which company is the subject of this filing?
The subject company is GERON CORP, with CIK 0000886744, a pharmaceutical preparations company based in Foster City, CA.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., a security brokers, dealers & flotation company with CIK 0001364742, based in New York, NY.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of Geron Corp. is 374163103.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding GERON CORP (GERN).